Home › Laryngeal Cancer › Iowa › Ames
Laryngeal Cancer clinical trials in Ames, IA
3 studies for Laryngeal Cancer are looking for participants at sites in and around Ames (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- McFarland Clinic - Ames, Ames
Laryngeal Cancer trials in other cities
- Atlanta, GA8 studies
- Chicago, IL8 studies
- Milwaukee, WI8 studies
- Kansas City, MO7 studies
- St. Louis, MO7 studies
- Portland, OR7 studies
- Edison, NJ6 studies
- Richmond, VA6 studies
- Baltimore, MD6 studies
- Cincinnati, OH6 studies
- Durham, NC6 studies
- Pittsburgh, PA6 studies
Other studies in Ames
- Prostate Cancer7 studies
- Lung Cancer7 studies
- Non-Small Cell Lung Cancer6 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Breast Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Bladder Cancer4 studies
- Chronic Lymphocytic Leukemia3 studies
- Hypopharyngeal Cancer3 studies
- Oral Cancer3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.